Screening for Gestational Diabetes Mellitus: Are the Criteria Proposed by the International Association of the Diabetes and Pregnancy Study Groups Cost-Effective?
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recently recommended new criteria for diagnosing gestational diabetes mellitus (GDM). This study was undertaken to determine whether adopting the IADPSG criteria would be cost-effective, compared with the current standard of care. RESEARCH DESIGN AND METHODS: We developed a decision analysis model comparing the cost-utility of three strategies to identify GDM: 1) no screening, 2) current screening practice (1-h 50-g glucose challenge test between 24 and 28 weeks followed by 3-h 100-g glucose tolerance test when indicated), or 3) screening practice proposed by the IADPSG. Assumptions included that 1) women diagnosed with GDM received additional prenatal monitoring, mitigating the risks of preeclampsia, shoulder dystocia, and birth injury; and 2) GDM women had opportunity for intensive postdelivery counseling and behavior modification to reduce future diabetes risks. The primary outcome measure was the incremental cost-effectiveness ratio (ICER). RESULTS: Our model demonstrates that the IADPSG recommendations are cost-effective only when postdelivery care reduces diabetes incidence. For every 100,000 women screened, 6,178 quality-adjusted life-years (QALYs) are gained, at a cost of $125,633,826. The ICER for the IADPSG strategy compared with the current standard was $20,336 per QALY gained. When postdelivery care was not accomplished, the IADPSG strategy was no longer cost-effective. These results were robust in sensitivity analyses. CONCLUSIONS: The IADPSG recommendation for glucose screening in pregnancy is cost-effective. The model is most sensitive to the likelihood of preventing future diabetes in patients identified with GDM using postdelivery counseling and intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The current criteria for the diagnosis of GDM introduced by The International Association of Diabetes and Pregnancy Study Groups (IADPSG), which were based on the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) results, found a threefold increase in GDM diagnoses, which suggests an earlier underestimation.”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [27]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The HAPO study demonstrated a positive linear relationship between screening glucose values and adverse perinatal outcomes. Moreover, the study authors found that perinatal risks began to increase in women with glucose values that were previously considered “normal” [27,28].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [27]
In the citing paper
“In a comparison of the 1-step with the 2-step protocols, 38 the 1-step protocol was predicted to be more costeffective than the 2-step protocol if GDMs receive postdelivery intensive counseling and care to prevent type 2 diabetes.”
From One-step or 2-step testing for gestational diabetes: which is better? (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
ACOG Practice Bulletin No. 30: Gestational Diabetes
(2001) · Obstetrics & Gynecology · doi:10.1097/00006250-200109000-00037 · Cited by 301
Retracted- Retracted
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Gynecologists (2009) · Cited by 1,037
Ratner, R. E., Christophi, C. A., Metzger, B. E., Dabelea, D., Bennett, P. H., Pi-Sunyer, X., Fowler, S., Kahn, S. E., & The Diabetes Prevention Program Research Group (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0772 · Cited by 867
Research works printed but not linked: 1
- 17. Macdorman MF, Kirmeyer S. The challenge of fetal mortality. NCHS Data Brief 2009;16:1–8
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
“counseling and care to prevent type 2 diabetes (196).”
Background2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
“A cost-benefit estimation comparing the two strategies concluded that the onestep approach is cost-effective only if patients with GDM receive postdelivery counseling and care to prevent type 2 diabetes (89).”
Background2. Classification and Diagnosis of Diabetes
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603
“A cost-benefit estimation comparing the two strategies concluded that the onestep approach is cost-effective only if patients with GDM receive postdelivery counseling and care to prevent type 2 diabetes (62).”
BackgroundA Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
Coustan, D. R. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.203331 · Cited by 250
Gestational Diabetes Mellitus—Recent Literature Review
Modzelewski, R., Stefanowicz-Rutkowska, M. M., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195736 · Cited by 223
“Moreover, the study authors found that perinatal risks began to increase in women with glucose values that were previously considered “normal” [27,28].”
BackgroundCost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?
Siegel, K. R., Ali, M. K., Zhou, X., Ng, B. P., Jawanda, S., Proia, K., Zhang, X., Gregg, E. W., Albright, A. L., & Zhang, P. (2020) · Diabetes Care · doi:10.2337/dci20-0017 · Cited by 164
Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear
Cundy, T., Ackermann, E., & Ryan, E. A. (2014) · BMJ · doi:10.1136/bmj.g1567 · Cited by 158
Falavigna, M., Schmidt, M. I., Trujillo, J., Alves, L. F., Wendland, E. R., Torloni, M. R., Colagiuri, S., & Duncan, B. B. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.002 · Cited by 152
Spaight, C., Gross, J., Horsch, A., & Puder, J. J. (2016) · Endocrine Development · doi:10.1159/000439413 · Cited by 148
Colagiuri, S., Falavigna, M., Agarwal, M. M., Boulvain, M., Coetzee, E., Hod, M., Meltzer, S. J., Metzger, B., Omori, Y., Rasa, I., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.02.012 · Cited by 132
Lamain-de Ruiter, M., Kwee, A., Naaktgeboren, C. A., de Groot, I., Evers, I. M., Groenendaal, F., Hering, Y. R., Huisjes, A. J. M., Kirpestein, C., Monincx, W. M., et al. (2016) · BMJ · doi:10.1136/bmj.i4338 · Cited by 123
Brown, F. M., & Wyckoff, J. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0922-z · Cited by 122
“…efficacy and if at least 2% more patients are diagnosed with GDM. Similarly, Werner et al. found that the one-step method was also cost effective compared to the method at $20,336 per QALY if postdelivery counseling and behavior modification were provided to reduce future diabetes risks [64].”
MethodFarrar, D., Simmonds, M., Griffin, S., Duarte, A., Lawlor, D. A., Sculpher, M., Fairley, L., Golder, S., Tuffnell, D., Bland, M., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20860 · Cited by 117
Xu, T., Dainelli, L., Yu, K., Ma, L., Silva Zolezzi, I., Detzel, P., & Fang, H. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018893 · Cited by 116
Werner, E. F., Hauspurg, A. K., & Rouse, D. J. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001115 · Cited by 113
Self-citationGestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis
Mission, J. F., Ohno, M. S., Cheng, Y. W., & Caughey, A. B. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.06.048 · Cited by 111
“Prior cost analyses have investigated the effectiveness of using the 2h OGTT in comparison to the 1h GCT using the new IADPSG guidelines.(18,31) One prior analsis looking at using the 2h OGTT comared the cost of the 2h OGTT screening additional gestational diabetes mellitus (GDM) test (OGTT).”
MethodResultInfluentialGestational Diabetes Mellitus and Cardiovascular Risk after Pregnancy
Harreiter, J., Dovjak, G., & Kautzky-Willer, A. (2014) · Women's Health · doi:10.2217/whe.13.69 · Cited by 106
“Cost–effectiveness analyses revealed that new International Association of Diabetes and Pregnancy Study Group (IADPSG) criteria are effective when postpartum monitoring is able to prevent diabetes progression [114].”
BackgroundClassification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 112
Sheiner, E., Kapur, A., Retnakaran, R. R., Hadar, E., Poon, L. C., McIntyre, D. H., Divakar, H., Staff, A. C., Narula, J., Kihara, A., et al. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12926 · Cited by 100
Hod, M., Kapur, A., & McIntyre, H. D. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.01.206 · Cited by 81
Zhang, X., Liao, Q., Wang, F., & Li, D. (2018) · Medicine · doi:10.1097/md.0000000000011891 · Cited by 77
Bhavadharini, B., Uma, R., Saravanan, P., & Mohan, V. (2016) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-016-0031-y · Cited by 75
“Because of the low fasting cut point, the IADPSG criteria has been reported to result in increased prevalence rates of GDM and this increases the burden on the health care system in many countries [21–23].”
BackgroundMarseille, E., Lohse, N., Jiwani, A., Hod, M., Seshiah, V., Yajnik, C. S., Arora, G. P., Balaji, V., Henriksen, O., Lieberman, N., et al. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.765845 · Cited by 76
Fasting plasma glucose to avoid a full OGTT in the diagnosis of gestational diabetes
Trujillo, J., Vigo, Á., Reichelt, A. J., Duncan, B. B., & Schmidt, M. I. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.06.001 · Cited by 105
Lovati, E., Beneventi, F., Simonetta, M., Laneri, M., Quarleri, L., Scudeller, L., Albonico, G., Locatelli, E., Cavagnoli, C., Tinelli, C., et al. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.04.002 · Cited by 85
Benhalima, K., Mathieu, C., Damm, P., Van Assche, A., Devlieger, R., Desoye, G., Corcoy, R., Mahmood, T., Nizard, J., Savona-Ventura, C., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3615-7 · Cited by 72
Diagnosis of Gestational Diabetes
Coustan, D. R., & Carpenter, M. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-56440-1_2 · Cited by 72
Changing trends in management of gestational diabetes mellitus
Poomalar, G. K. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.284 · Cited by 68
Diagnosis of GDM: A suggested consensus
McIntyre, D. H., Colagiuri, S., Roglić, G., & Hod, M. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.04.022 · Cited by 77
Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy
Dickens, L. T., & Thomas, C. C. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1147-0 · Cited by 83
Trujillo, J., Vigo, A., Duncan, B. B., Falavigna, M., Wendland, E. M., Campos, M. A., & Schmidt, M. I. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.02.007 · Cited by 64
“found that the IADPSG recommendations were cost-effective only when post-delivery counseling and intervention strategies to reduce future diabetes incidence in the mother are considered [27].”
BackgroundBilous, R. W., Jacklin, P., Maresh, M., & Sacks, D. A. (2021) · Diabetes Care · doi:10.2337/dc20-2941 · Cited by 72
Wei, J., Heng, W., & Gao, J. (2016) · Medicine · doi:10.1097/md.0000000000003792 · Cited by 62
Screening and management of gestational diabetes
Benhalima, K., Devlieger, R., & Assche, A. V. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.07.026 · Cited by 78
“10 Thus far, two studies have addressed the cost-effectiveness of GDM screening according to the IADPSG criteria using decision analysis models for a US population [54,55].”
BackgroundMethodHung, T.-H., & Hsieh, T.-T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122261 · Cited by 61
“diagnosis are more cost-effective than the two-step method, however, only if post-delivery consultation and intervention are provided to reduce the frequency of type 2 diabetes mellitus [25].”
MethodDiagnosis of gestational diabetes
Coustan, D. R. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.936677 · Cited by 64
Lindqvist, M., Persson, M., Lindkvist, M., & Mogren, I. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-185 · Cited by 55
Occurrence and recurrence of diabetes in pregnancy
Khambalia, A. Z., Ford, J. B., Nassar, N., Shand, A. W., McElduff, A., & Roberts, C. L. (2013) · Diabetic Medicine · doi:10.1111/dme.12124 · Cited by 55
Werner, E. F., Has, P., Rouse, D., & Clark, M. A. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.05.036 · Cited by 52
Self-citationTasillo, A., Yazdi, G. E., Nolen, S., Schillie, S. F., Vellozzi, C. J., Epstein, R. L., Randall, L. M., Salomon, J. A., & Linas, B. P. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003062 · Cited by 53
Sevket, O., Ates, S., Uysal, O., Molla, T., Dansuk, R., & Kelekci, S. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.799656 · Cited by 49
Goldhaber‐Fiebert, J. D., & Brandeau, M. L. (2015) · Medical Decision Making · doi:10.1177/0272989x15583845 · Cited by 56
Huhn, E. A., Massaro, N., Streckeisen, S., Manegold-Brauer, G., Schoetzau, A., Schulzke, S. M., Winzeler, B., Hoesli, I., & Lapaire, O. (2017) · Journal of Perinatal Medicine · doi:10.1515/jpm-2016-0099 · Cited by 47
Diabetes: An Update on the Pandemic and Potential Solutions
Ali, M. K., Siegel, K. R., Chandrasekar, E. K., Tandon, N., Montoya, P. A., Mbanya, J. C., Chan, J. C. N., Zhang, P., & Narayan, K. M. V. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0518-9_ch12 · Cited by 71
Kong, J. M., Lim, K. I., & Thompson, D. M. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.09.007 · Cited by 46
Pintaudi, B., Di Vieste, G., Corrado, F., Lucisano, G., Pellegrini, F., Giunta, L., Nicolucci, A., D'Anna, R., & Di Benedetto, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0759 · Cited by 44
In Pursuit of Value-Based Maternity Care
Sudhof, L. S., & Shah, N. T. (2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003113 · Cited by 46
Gestational Diabetes Mellitus: Screening and Outcomes in Southern Italian Pregnant Women
Capula, C., Chiefari, E., Vero, A., Arcidiacono, B., Iiritano, S., Puccio, L., Pullano, V., Foti, D. P., Brunetti, A., & Vero, R. (2013) · ISRN Endocrinology · doi:10.1155/2013/387495 · Cited by 43
“Hindawi Publishing Corporation ISRN Endocrinology Volume 2013, Article ID 387495, 8 pages http://dx.doi.org/10.1155/2013/387495”
BackgroundInfluentialBenhalima, K., Van Crombrugge, P., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., Dufraimont, E., De Block, C., Jacquemyn, Y., Mekahli, F., et al. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-226 · Cited by 43
“One study showed that the IADPSG recommendations are cost effective only when post-delivery care reduces diabetes incidence [17].”
BackgroundLinks between maternal health and NCDs
Kapur, A. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.04.016 · Cited by 52
Prediction of gestational diabetes mellitus at first trimester in low-risk pregnancies
Kumru, P., Arisoy, R., Erdogdu, E., Demirci, O., Kavrut, M., Ardıc, C., Aslaner, N., Ozkoral, A., & Ertekin, A. (2016) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2016.04.032 · Cited by 41
One-step or 2-step testing for gestational diabetes: which is better?
Coustan, D. R., Dyer, A. R., & Metzger, B. E. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.05.009 · Cited by 40
The diagnostic criteria for gestational diabetes: to change or not to change?
Reece, E. A., & Moore, T. R. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.887 · Cited by 41
Freebairn, L., Occhipinti, J., Kelly, P., McDonnell, G., & Rychetnik, L. (2016) · Health Research Policy and Systems · doi:10.1186/s12961-016-0143-y · Cited by 51
Establishing Consensus in the Diagnosis of Gestational Diabetes Following HAPO: Where Do We Stand?
Long, H., & Cundy, T. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0330-3 · Cited by 43
Kapur, A., & Hod, M. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13198 · Cited by 46
Koivunen, S., Kajantie, E., Torkki, A., Bloigu, A., Gissler, M., Pouta, A., & Vääräsmäki, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0294 · Cited by 37
Shahbazian, H., Nouhjah, S., Shahbazian, N., Jahanfar, S., Latifi, S. M., Aleali, A., Shahbazian, N., & Saadati, N. (2016) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2016.06.019 · Cited by 37
Gestational Diabetes Mellitus: Is It Time to Reconsider the Diagnostic Criteria?
Cheung, N. W., & Moses, R. G. (2018) · Diabetes Care · doi:10.2337/dci18-0013 · Cited by 35
“Finally, the cost-effectiveness remains questionable, with retrospective observational studies giving conflicting results (9,10).”
Thyroid Screening in Early Pregnancy: Pros and Cons
Taylor, P. N., Zouras, S., Min, T., Nagarahaj, K., Lazarus, J. H., & Okosieme, O. E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00626 · Cited by 43
Is the evidence strong enough to change the diagnostic criteria for gestational diabetes now?
Visser, G. H. A., & de Valk, H. W. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.881 · Cited by 45
Evolution of diagnostic criteria for gestational diabetes mellitus
Houshmand‐Oeregaard, A. S., Jensen, D. M., Mathiesen, E. R., & Damm, P. (2013) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12152 · Cited by 42
Gestational Diabetes: An Update 60 Years After O’Sullivan and Mahan
McIntyre, H. D., Kampmann, U., Dalsgaard Clausen, T., Laurie, J., & Ma, R. C. W. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae709 · Cited by 32
Einarson, T. R., Bereza, B. G., Acs, A., & Jensen, R. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1257977 · Cited by 36
Hamel, M. S., & Werner, E. F. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0835-x · Cited by 35
Self-citationJacklin, P. B., Maresh, M. J., Patterson, C. C., Stanley, K. P., Dornhorst, A., Burman-Roy, S., & Bilous, R. W. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016621 · Cited by 31
Global cost-effectiveness of GDM screening and management: Current knowledge and future needs
Weile, L. K. K., Kahn, J. G., Marseille, E. A., Jensen, D. M., Damm, P., & Lohse, N. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.06.009 · Cited by 35
Perspectives on the Proposed Gestational Diabetes Mellitus Diagnostic Criteria
Langer, O., Umans, J. G., & Miodovnik, M. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31827711e5 · Cited by 34
The post-HAPO situation with gestational diabetes: the bright and dark sides
Lapolla, A., & Metzger, B. E. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1146-7 · Cited by 30
Helseth, R., Salvesen, Ø., Stafne, S. N., Mørkved, S., Salvesen, K. A., & Carlsen, S. M. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.928942 · Cited by 30
Economic evaluations of gestational diabetes mellitus screening: a systematic review
Mo, X., Gai Tobe, R., Takahashi, Y., Arata, N., Liabsuetrakul, T., Nakayama, T., & Mori, R. (2021) · Journal of Epidemiology · doi:10.2188/jea.je20190338 · Cited by 29
Falavigna, M., Prestes, I. V., Schmidt, M. I., Duncan, B. B., Colagiuri, S., & Roglić, G. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.009 · Cited by 35
The proposed GDM diagnostic criteria: a difference, to be a difference, must make a difference
Langer, O., Umans, J. G., & Miodovnik, M. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.734874 · Cited by 31
Talasaz, Z. H., Sadeghi, R., Askari, F., Dadgar, S., & Vatanchi, A. (2018) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2018.02.003 · Cited by 28
Huhn, E. A., Fischer, T., Göbl, C. S., Bernasconi, M. T., Kreft, M., Kunze, M., Schoetzau, A., Dölzlmüller, E., Eppel, W., Husslein, P. W., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012115 · Cited by 33
Gestational diabetes and the neonate: challenges and solutions
Malhotra, A. K., & Stewart, A. (2015) · Research and Reports in Neonatology · doi:10.2147/rrn.s30971 · Cited by 38
“However, the recommendations have not been uniformly adopted, and debate remains regarding the costs, risks, and benefits.(11,77) Hence, the issue of optimal screening criteria for GDM remains unresolved.”
Göbl, C. S., Bozkurt, L., Rivic, P., Schernthaner, G.-H., Weitgasser, R., Pacini, G., Mittlböck, M., Bancher‐Todesca, D., Lechleitner, M., & Kautzky‐Willer, A. (2012) · Diabetologia · doi:10.1007/s00125-012-2726-7 · Cited by 28
Screening for gestational diabetes in Europe: where do we stand and how to move forward?
Benhalima, K., Damm, P., Assche, A. V., Mathieu, C., Devlieger, R., Mahmood, T. A., & Dunne, F. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.04.002 · Cited by 36
Danyliv, A., Gillespie, P., O’Neill, C., Tierney, M., O’Dea, A., McGuire, B. E., Glynn, L. G., & Dunne, F. (2015) · Diabetologia · doi:10.1007/s00125-015-3824-0 · Cited by 25
Diagnostic Strategies for Gestational Diabetes Mellitus: Review of Current Evidence
Kuo, C., & Li, H. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1271-x · Cited by 31
Contribution of Artificial Intelligence in Pregnancy: A Scoping Review
Abuelezz, I., Hassan, A. O., Jaber, B. A., Sharique, M., Abd-Alrazaq, A. A., Househ, M. S., Alam, T., & Shah, Z. (2022) · Studies in health technology and informatics · doi:10.3233/shti210927 · Cited by 36
“%) employed AI techniques for treatment and management of ectopic pregnancies [22], gestational diabetes [23], late-onset preeclampsia [5], and hypertensive disorder [10].”
Gestational diabetes - on broadening the diagnosis
Casey, B. (2021) · New England Journal of Medicine · doi:10.1056/nejme2100902 · Cited by 23
Mahmoud, E., Elsayed, A. M., Elsayed, B. M. S., Elsalakawi, Y., Gopinath, A., & Chivese, T. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-091258 · Cited by 34
Gestational Diabetes Mellitus: Implications of an Increased Frequency With IADPSG Criteria
Moses, R. G. (2012) · Diabetes Care · doi:10.2337/dc11-2237 · Cited by 27
Evaluation of a Self-Administered Oral Glucose Tolerance Test
Bethel, M. A., Price, H. C., Sourij, H., White, S. J., Coleman, R. L., Ring, A., Kennedy, I., Tucker, L., & Holman, R. R. (2013) · Diabetes Care · doi:10.2337/dc12-0643 · Cited by 21
Vitacolonna, E., Succurro, E., Lapolla, A., Scavini, M., Bonomo, M. A., Cianni, G. D., Benedetto, A. D., Napoli, A., Tumminia, A., Festa, C., et al. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01397-4 · Cited by 27
Lin, J., Zhao, D., Liang, Y., Liang, Z., Wang, M., Tang, X., Zhuang, H., Wang, H., Yin, X., Huang, Y., et al. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06919-9 · Cited by 25
“This method is cost-effective only when GDM patients receive postpartum counseling and care to prevent type II diabetes [22].”
MethodSénat, M., & Deruelle, P. (2016) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2016.01.009 · Cited by 38
Coustan, D. R. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.186239 · Cited by 24
Treatment of gestational diabetes diagnosed by the IADPSG criteria decreases excessive fetal growth
Lee, K., Han, Y. J., Chung, J. H., Kim, M. Y., Ryu, H., Kim, J.-H., Kwak, D.-W., Kim, S.-H., Yang, S., & Kim, M. H. (2020) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2020.63.1.19 · Cited by 21
Chen, P. Y., Finkelstein, E. A., Ng, M. J., Yap, F. K. P., Yeo, G. S., Rajadurai, V. S., Chong, Y. S., Gluckman, P. D., Saw, S., Kwek, K. Y. C., et al. (2015) · Asia Pacific Journal of Public Health · doi:10.1177/1010539515612908 · Cited by 20
“Screened/treated GDM–Category A 38·24 (10-90) a”
MethodInfluentialAssessment of Eating Behaviors and Perceptions of Time-Restricted Eating During Pregnancy
Flanagan, E. W., Kebbe, M., Sparks, J. R., & Redman, L. M. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab397 · Cited by 15
Metadata
- Authors
- Werner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F.
- Affiliations
- Johns Hopkins University (US)
- Yale University (US)
- The Ohio State University (US)
- Corresponding author
- Werner, Erika F.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-02-10
- Volume
- 35
- Issue
- 3
- Pages
- 529-535
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3322683
- OpenAlex
- W2171826023
- Cited by
- 182
- References
- 43
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 9 · 2023: 2 · 2022: 9 · 2021: 11 · 2020: 8 · 2019: 15 · 2018: 14 · 2017: 16 · 2016: 20 · 2015: 17 · 2014: 18 · 2013: 18 · 2012: 16
- FWCI
- 26.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, IADPSG criteria, cost-effectiveness, glucose challenge test, glucose tolerance test, postpartum counseling, diabetes prevention, quality-adjusted life years, decision-analytic model
- MeSH terms
- Cost-Benefit Analysis, Female, Glucose Tolerance Test, Humans, Mass Screening, Pregnancy, Diabetes, Gestational, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
